BOSTON--(BUSINESS WIRE)--AVS (Amplitude Vascular Systems, Inc), an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ ...

MINNEAPOLIS, May 7, 2025 /PRNewswire/ -- FastWave Medical, a pioneering intravascular lithotripsy (IVL) startup, has secured Institutional Review Board (IRB) approval to commence a coronary ...

The SKYWARD programme includes two planned prospective, multi-centre, single-arm IDE studies.

SANTA CLARA, Calif., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved, but procedure-related morbidity remains a concern. A new study published today in the Journal of ...

POWER CAD I study will evaluate feasibility of the Pulse IVL™ system in patients with severely calcified coronary arterial disease Amplitude Vascular Systems (AVS), a medical device company recently ...

WASHINGTON, DC—Early experience with intravascular lithotripsy (IVL) to modify severe coronary calcium before stent implantation shows that the technology is a safe and feasible alternative to ...

Abbott Laboratories emphatically let Boston Scientific and Johnson & Johnson know it wanted a piece of the intravascular lithotripsy (IVL) space. The Abbott Park, IL-based company reported FDA had ...

One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug-coated balloon (DCB) to percutaneous transluminal angioplasty (PTA) with a DCB was presented ...

Malaysian cardiologists have successfully demonstrated a new, more efficient way to treat calcified plaques blocking blood ...